Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02983604 |
Title | GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer |
Recruitment | Terminated |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford Women's Cancer Center | Stanford | California | 94305 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Allina Health, Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | United States | Details | |
The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Baylor University Medical Center | Houston | Texas | 77030 | United States | Details | |
Medical Oncology Associates, PS (dba Summit Cancer Centers) | Spokane | Washington | 99208 | United States | Details |